Targeting WNT/β-Catenin via Modulating EZH2 Function: A New Chapter in the Treatment of β-Catenin Mutant Hepatocellular Carcinoma?

被引：1
|
作者：
Hung, Man Hsin [1 ]
Wang, Xin Wei [1 ,2 ,3 ,4 ]
机构：
[1] NCI, Ctr Canc Res, Lab Human Carcinogenesis, Bethesda, MD USA
[2] NCI, Ctr Canc Res, Liver Canc Program, Bethesda, MD USA
[3] NCI, Lab Human Carcinogenesis, Bethesda, MD 20892 USA
[4] NCI, Liver Canc Program, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2023年 / 83卷 / 21期
关键词：
MICE;
D O I：
10.1158/0008-5472.CAN-23-2921
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In a recent study, Rialdi and colleagues identified a specific vulnerability in beta-catenin mutant hepatocellular carcinoma (HCC) via EZH2-mediated suppression of WNT signaling and revealed the selective anti-HCC activity of WNTinib, a chemical derivative of regorafenib and sorafenib in targeting this vulnerability. Their discoveries highlight the role of EZH2 in modulating WNT signaling and suggest an implication of WNTinihb as a small-molecule inhibitor for the treatment of HCC with activated WNT/beta-catenin.
引用
收藏
页码：3498 / 3500
页数：3
相关论文
共 50 条
  • [1] miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway
    Zhang, Jun-Jie
    Chen, Jiang-Tao
    Hua, Long
    Yao, Kun-Hou
    Wang, Chen-Yu
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 85 : 472 - 478
  • [2] Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment
    Vilchez, Valery
    Turcios, Lilia
    Marti, Francesc
    Gedaly, Roberto
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (02) : 823 - 832
  • [3] Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment
    Valery Vilchez
    Lilia Turcios
    Francesc Marti
    Roberto Gedaly
    World Journal of Gastroenterology, 2016, (02) : 823 - 832
  • [4] Polycomb protein EZH2 activates Wnt/β-catenin signaling to promote hepatocellular carcinoma development
    Cheng, Alfred S.
    Lau, Suki
    Chen, Yangchao
    Kondo, Yutaka
    Li, May
    Feng, Hai
    Ching, Arthur
    Cheung, Paul
    Wong, Kenneth
    Jin, Hongchuan
    Choy, Richard
    Yu, Jun
    To, Ka F.
    Wong, Nathalie
    Huang, Tim
    Sung, Joseph J.
    CANCER RESEARCH, 2010, 70
  • [5] Targeting EZH2 Ameliorates the LPS-Inhibited PDLSC Osteogenesis via Wnt/β-Catenin Pathway
    Cheng, Mosha
    Zhou, Qing
    CELLS TISSUES ORGANS, 2021, 209 (4-6) : 227 - 235
  • [6] Wnt secretion is not required to sustain Wnt/β-catenin signaling in β-catenin mutant hepatocellular carcinoma cells
    Wang, W.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S163 - S163
  • [7] PAF and EZH2 Induce Wnt/β-Catenin Signaling Hyperactivation
    Jung, Hae-Yun
    Jun, Sohee
    Lee, Moonsup
    Kim, Han-Cheon
    Wang, Xin
    Ji, Hong
    McCrea, Pierre D.
    Park, Jae-Il
    MOLECULAR CELL, 2013, 52 (02) : 193 - 205
  • [8] EZH2 Impairs Human Dental Pulp Cell Mineralization via the Wnt/β-Catenin Pathway
    Li, B.
    Yu, F.
    Wu, F.
    Hui, T.
    Liao, X.
    Yin, B.
    Wang, C.
    Ye, L.
    JOURNAL OF DENTAL RESEARCH, 2018, 97 (05) : 571 - 579
  • [9] Stratifin Promotes Hepatocellular Carcinoma Progression by Modulating the Wnt/β-Catenin Pathway
    Ye, Shan-Ping
    Yu, Hong-Xin
    Lu, Wei-Jie
    Wang, Jun-Fu
    Li, Tai-Yuan
    Shi, Jun
    Cheng, Xiao-Ye
    INTERNATIONAL JOURNAL OF GENOMICS, 2023, 2023
  • [10] The inhibition of EZH2 ameliorates osteoarthritis development through the Wnt/β-catenin pathway
    Chen, Linwei
    Wu, Yaosen
    Wu, Yan
    Wang, Ye
    Sun, Liaojun
    Li, Fangcai
    SCIENTIFIC REPORTS, 2016, 6
12345